Competing risks analysis of recurrent venous thromboembolism ( VTE) and bleeding on anticoagulation in patients with cancer-associated VTE

被引：0
|
作者：
Simon, David [1 ]
Le Mao, Raphael [2 ]
Raj, Leela [3 ]
Espinasse, Benjamin [2 ]
De Moreuil, Claire [2 ]
Tromeur, Cecile [2 ]
Guegan, Marie [1 ]
Poulhazan, Elise [1 ]
Le Moigne, Emmanuelle [2 ]
Lacut, Karine [2 ]
Leroyer, Christophe [2 ]
Mahe, Isabelle [4 ,5 ]
Nowak, Emmanuel [1 ]
Couturaud, Francis [2 ]
机构：
[1] Univ Brest, FCRIN INNOVTE, CHU Brest, CIC1412 INSERM,INSERM U1304GETBO, Brest, France
[2] Univ Brest, FCRIN INNOVTE, CHU Brest, Dept Med Interne & Pneumol,INSERM U1304 GETBO, Brest, France
[3] Western Univ, Schulich Sch Med & Dent, London, ON, Canada
[4] Hop Louis Mourier, AP HP, Serv Med Interne, F-92700 Colombes, France
[5] Univ Paris Cite, INSERM UMR S1140 7, F-75006 Paris, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2245
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Predicting the risk of recurrent venous thromboembolism (VTE)
    Streiff, Michael B.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (03) : 353 - 366
  • [32] Evaluation of direct oral anticoagulant use for cancer-associated venous thromboembolism (VTE) in lung cancer
    Rostamnjad, Leila
    Dagogo-Jack, Ibiayi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [33] Venous thromboembolism (VTE) in patients with lung cancer (LC)
    Campayo, M.
    Font, C.
    Farrus, B.
    Reverter, J. C.
    Tassies, D.
    Reguart, N.
    Vinolas, N.
    Gascon, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Recurrent VTE in cancer patients treated with anticoagulation.
    Streiff, Michael Blake
    Milentijevic, Dejan
    McCrae, Keith
    Yannicelli, Daniel
    Fortier, Jonathan
    Nelson, Winnie W.
    Laliberte, Francois
    Crivera, Concetta
    Lefebvre, Patrick
    Schein, Jeff
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study
    Douce, Daniel R.
    Holmes, Chris E.
    Cushman, Mary
    MacLean, Charles D.
    Ades, Steven
    Zakai, Neil A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (12) : 2152 - 2159
  • [36] Venous thromboembolism and cancer: Prevention of VTE
    Bergqvist, D
    THROMBOSIS RESEARCH, 2001, 102 (06) : V209 - V213
  • [37] Factors That Predict The Risk Of Recurrent Venous Thromboembolism (VTE) In Patients With VTE And Factor V Leiden (FVL)
    Couturaud, F.
    Noel-Savina, E.
    Paleiron, N.
    Quere, G.
    Mottier, D.
    Leroyer, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [38] Venous Thromboembolism (VTE) in Cancer Patients Receiving Chemotherapy: a Real-world Analysis of VTE Risk and the Impact of VTE on Healthcare Expenditure
    Lyman, G. H.
    Wang, Y.
    Wang, H.
    Cohen, A. T.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S222 - S222
  • [39] SurvLatent ODE : A Neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated Venous Thromboembolism (VTE) prediction
    Moon, Intae
    Groha, Stefan
    Gusev, Alexander
    MACHINE LEARNING FOR HEALTHCARE CONFERENCE, VOL 182, 2022, 182 : 800 - 827
  • [40] Risk factors for major bleeding during prolonged anticoagulation therapy in cancer-associated venous thromboembolisms: from the COMMAND VTE registry
    Nishimoto, Y.
    Yamashita, Y.
    Kim, K.
    Morimoto, T.
    Saga, S.
    Sato, Y.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3258 - 3258
12345